Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 17.70 Delayed Data As of 4:00pm ET |  -0.41 / -2.26%Today’s Change | 17.22 Today|||52-Week Range 26.91 | -5.25% Year-to-Date |
Latest COLL News | Press Releases
No recent news for Collegium Pharmaceutical Inc.
Today’s Trading
| Previous close | 18.11 |
| Today’s open | 17.58 |
| Day’s range | 17.34 - 18.25 |
| Volume | 4,893 |
| Average volume (3 months) | 268,587 |
| Market cap | $614.3M |
Data as of 4:00pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -0.15% |
| Earnings growth (next 5 years) | +42.00% |
| Revenue growth (last year) | +4.49% |
| P/E ratio | 6.8 |
| Price/Sales | 2.27 |
| Price/Book | 3.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IDYAIDEAYA Biosciences I... | -0.55 | -3.39% |
| ---- | ||
| ACRSAclaris Therapeutics... | -0.19 | -1.81% |
| TBPHTheravance Biopharma... | +0.01 | +0.11% |
Data as of 4:00pm ET, 01/26/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | $1.04 |
| Annual revenue (last year) | $310.0M |
| Annual profit (last year) | $26.8M |
| Net profit margin | 8.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Stoughton, Massachusetts |
Forecasts
